SEC Form 4 · accession 0001610717-26-000386
10x Genomics, Inc. · TXG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Serge Saxonov
Officer — Chief Executive Officer · Director
Period of report
Aug 20, 2026
Accepted (ET)
Aug 24, 2026 · 4:16 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001770787
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Aug 20, 2026 | G | 4,000 | $0.00 | D | 1,104,380 | D | |
| Class A Common StockF1 | holding | — | — | — | 27 | I | See footnote | |
| Class A Common StockF2 | holding | — | — | — | 213,250 | I | See footnote | |
| Class A Common StockF3 | holding | — | — | — | 71,644 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.
- F2The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.
- F3The shares are held by the Y/S Pot Trust, for which the Reporting Person serves as trustee.